Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3858 results

Sort By:

Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)

Study ID: NCT07187778
Start Date: 2026-02-28
End Date: 2029-07-19
Study Type

Interventional

Study Phase

Phase2

No. of Participants

10

Intervention / Treatment

Pembrolizumab

in Belzutifa

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Impact of Blood Cultures Drawn From Arterial Lines on the Incidence of Contamination, Detection of Bacteremia, and Blood Culture Volume

Study ID: NCT07183410
Start Date: 2026-01-01
End Date: 2028-06-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1500

Intervention / Treatment

Blood culture taken from an arterial catheter

Sponsor

Meir Medical Center

Source: clinicaltrials.gov

Share:
Add to list

FELLAShip to Better Health

Study ID: NCT07220213
Start Date: 2026-01-01
End Date: 2026-07-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

90

Intervention / Treatment

Black Impact

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Innovating Technology Solutions for Residents in Support Housing Communities w SUD Through Community-Engaged Research

Study ID: NCT07001020
Start Date: 2026-01
End Date: 2026-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

Technology-based Intervention

Sponsor

Oregon Research Behavioral Intervention Strategies, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis

Study ID: NCT07122089
Start Date: 2026-01-02
End Date: 2030-01-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Selective Internal Radiotherapy

Tremelimumab

Durvalumab

Sponsor

Center Eugene Marquis

Source: clinicaltrials.gov

Share:
Add to list

Doxycycline Boosted Therapy in Lyme Borreliosis: DoBo Study.

Study ID: NCT07230028
Start Date: 2026-03-01
End Date: 2027-11-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

50

Intervention / Treatment

Hydroxychloroquin

Placebo

Doxycycline

Sponsor

Radboud University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

Study ID: NCT07175415
Start Date: 2026-10-01
End Date: 2032-10-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

42

Intervention / Treatment

Capivasertib

Venetoclax

Dexamethasone

Intrathecal chemotherapy

Sponsor

Princess Maxima Center for Pediatric Oncology

Source: clinicaltrials.gov

Share:
Add to list

Physician- and Patient-based Barriers to NGS Testing

Study ID: NCT07209176
Start Date: 2026-01-15
End Date: 2027-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

256

Intervention / Treatment

Provider-level and patient education at end of study

Provider-level and patient-level

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

REstoring Flow by REvascularization With Submaximal Angioplasty in Hemodynamic IntraCranial Atherosclerotic Stenosis

Study ID: NCT03729817
Start Date: 2027-10
End Date: 2032-10-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

159

Intervention / Treatment

Submaximal balloon angioplasty

Sponsor

Case Western Reserve University

Source: clinicaltrials.gov

Share:
Add to list

Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis

Study ID: NCT06609343
Start Date: 2026-02-02
End Date: 2027-01-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

16

Intervention / Treatment

Bupropion Hydrochloride 150 MG

Sponsor

The University of Texas Health Science Center at San Antonio

Source: clinicaltrials.gov

Share:
Add to list